嵌合抗原受体自然杀伤(CAR-NK)细胞治疗乳腺癌的疗效与安全性评价:系统综述与荟萃分析
Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Evaluation of Efficacy and Safety of Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cells in Breast Cancer: A Systematic Review and Meta-Analysis.
CAR-T therapy in non-small cell lung cancer: Clinical prospects, potential, and strategies for cardiotoxicity management.
Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors.
Chimeric antigen receptor NK cells for breast cancer immunotherapy.
Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer.
Pan-Cancer Analysis Identifies Tumor Cell Surface Targets for CAR-T Cell Therapies and Antibody Drug Conjugates.
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer.
共 7 条
MEMBER ACCOUNT
登录成功会直接打开下一页。